ATM polymorphism is associated with low risk myelodysplastic syndrome

DNA Repair

Volumn 12, Issue 2, 2013, Pages 87-89

  Ribeiro, Howard Lopes ^a   De Oliveira, Roberta Taiane Germano ^a   Maia, Allan Rodrigo Soares ^a   De Sousa, Juliana Cordeiro ^a   Heredia, Fabiola Fernandes ^a   Magalhães, Silvia Maria Meire ^a   Pinheiro, Ronald Feitosa ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN;

DNA DAMAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LETTER; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BRAZIL; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MYELODYSPLASTIC SYNDROMES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84872491877     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2012.10.010     Document Type: Letter

References (11)

1. Cazzola M., Della Porta M.G., Travaglino E., Malcovati L. Classification and prognostic evaluation of myelodysplastic syndromes. Semin. Oncol. 2011, 38(Suppl. 5):627-634.
2. Brunning R.D., Orazi A., Germing U. Myelodysplastic syndromes/neoplasms, verview. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues 2008, IARC Press, Lyon, pp. 88-93. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman (Eds.).
3. Strom S.S., Vélez-Bravo V., Estey E.H. Epidemiology of myelodysplastic syndromes. Semin. Hematol. 2008, 45(January (1)):8-13.
4. Abraham R.T. PI 3-kinase related kinases: 'big' players in stressinduced signaling pathways. DNA Repair (Amst) 2004, 3:883-887.
5. Stankovic T., Kidd A.M., Sutcliffe A., McGuire G.M., Robinson P., Weber P., Bedenham T., Bradwell A.R., Easton D.F., Lennox G.G., Haites N., Byrd P.J., Taylor A.M. ATM mutations and phenotypes in ataxia-telangiectasia families in the British isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet. 1998, 62:334-345.
6. Renwick A., Thompson D., Seal S., Kelly P., Chagtai T., Ahmed M., North B., Jayatilake H., Barfoot R., Spanova K., McGuffog L., Evans D.G., Eccles D., Easton D.F., Stratton M.R., Rahman N. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet. 2006, 38:873-875.
7. Thompson D., Duedal S., Kirner J., McGuffog L., Last J., Reiman A., Byrd P., Taylor M., Easton D.F. Cancer risks and mortality in heterozygous ATM mutation carriers. J. Natl. Cancer Inst. 2005, 97:813-822.
8. Wang K., Ye Y., Xu Z., Zhang X., Hou Z., Cui Y., Song Y. Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population. Cancer Genet. Cytogenet. 2010, 1:40-46.
9. Wang C.-H., Wu K.-H., Yang Y.-L., Peng C.-T., Tsai F.-J., Lin D.-T., Chiu C.-F., Lin C.-C., Bau D.-T. Association between ataxia telangiectasia mutated gene polymorphisms and childhood leukemia in Taiwan. Chin. J. Physiol. 2011, 54. 6 413-418.
10. Chauffaille M.L. Adding FISH to karyotype in Myelodysplastic syndrome investigation diagnosis: are all questions answered?. Leuk Res. 2010, 34(April (4)):413-415.
11. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.